GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » E10

Albert David (BOM:524075) E10 : ₹64.71 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Albert David's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹22.530. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹64.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Albert David's average E10 Growth Rate was 22.30% per year. During the past 3 years, the average E10 Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Albert David was 14.00% per year. The lowest was 14.00% per year. And the median was 14.00% per year.

As of today (2024-05-31), Albert David's current stock price is ₹1114.50. Albert David's E10 for the quarter that ended in Mar. 2024 was ₹64.71. Albert David's Shiller PE Ratio of today is 17.22.

During the past 13 years, the highest Shiller PE Ratio of Albert David was 23.77. The lowest was 8.15. And the median was 11.61.


Albert David E10 Historical Data

The historical data trend for Albert David's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David E10 Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 43.64 46.44 52.89 64.71

Albert David Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.89 57.63 59.91 64.17 64.71

Competitive Comparison of Albert David's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Albert David's Shiller PE Ratio falls into.



Albert David E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Albert David's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=22.53/153.0345*153.0345
=22.530

Current CPI (Mar. 2024) = 153.0345.

Albert David Quarterly Data

per share eps CPI Adj_EPS
201406 3.360 94.103 5.464
201409 12.370 96.780 19.560
201412 1.170 96.780 1.850
201503 7.110 97.163 11.198
201506 4.890 99.841 7.495
201509 11.200 101.753 16.845
201512 -9.030 102.901 -13.429
201603 77.030 102.518 114.987
201606 5.800 105.961 8.377
201609 12.420 105.961 17.938
201612 -1.860 105.196 -2.706
201703 11.600 105.196 16.875
201706 -14.560 107.109 -20.803
201709 14.620 109.021 20.522
201712 7.050 109.404 9.862
201803 10.120 109.786 14.107
201806 13.740 111.317 18.889
201809 0.720 115.142 0.957
201812 19.240 115.142 25.572
201903 13.000 118.202 16.831
201906 16.280 120.880 20.611
201909 13.880 123.175 17.245
201912 9.200 126.235 11.153
202003 -5.770 124.705 -7.081
202006 -1.860 127.000 -2.241
202009 17.160 130.118 20.182
202012 10.720 130.889 12.534
202103 12.780 131.771 14.842
202106 18.300 134.084 20.886
202109 22.200 135.847 25.009
202112 13.960 138.161 15.463
202203 7.320 138.822 8.069
202206 3.080 142.347 3.311
202209 35.290 144.661 37.333
202212 18.480 145.763 19.402
202303 6.550 146.865 6.825
202306 41.160 150.280 41.914
202309 35.570 151.492 35.932
202312 32.800 152.924 32.824
202403 22.530 153.035 22.530

Add all the adjusted EPS together and divide 10 will get our e10.


Albert David  (BOM:524075) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Albert David's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1114.50/64.71
=17.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Albert David was 23.77. The lowest was 8.15. And the median was 11.61.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Albert David E10 Related Terms

Thank you for viewing the detailed overview of Albert David's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines